Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Rutenberg

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Oral and Maxillofacial Surgery Clinics of North America|April 28, 2023
Future Perspective: Carbon Ion Radiotherapy for Head and Neck and Skull Base MalignanciesMichael S Rutenberg, Chris Beltran
Journal of Gastrointestinal Oncology|March 17, 2020
Proton beam radiotherapy for pancreas cancerMichael S Rutenberg, Romaine C Nichols
Trends in Molecular Medicine|April 27, 2004
Cell fusion and reprogramming: resolving our transdifferencesNemanja Rodić, Michael S Rutenberg, Naohiro Terada
Current Hematologic Malignancy Reports|May 21, 2014
Proton therapy for Hodgkin lymphomaMichael S Rutenberg, Stella Flampouri, Bradford S Hoppe
Practical Radiation Oncology|December 13, 2024
Reirradiation in the Management of Locally Recurrent Rectal AdenocarcinomaMichael S Rutenberg, Michael D Chuong, Jessica M Frakes
Current Treatment Options in Oncology|March 2, 2021
The Role of Radiation Therapy for Symptomatic Desmoid TumorsWen Shen Looi, Daniel J Indelicato, Michael S Rutenberg
International Journal of Hematology|February 26, 2004
Stem cell plasticity, beyond alchemyMichael S Rutenberg, Takashi Hamazaki, Amar M Singh, et al.
Journal of Applied Clinical Medical Physics|April 26, 2024
Technical note: A comparison of in-house 3D-printed and commercially available patient-specific skin collimators for use with electron beam therapySteven M Herchko, Michael S Rutenberg, Chris J Beltran, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer: a phase II trialCooper T Rapp, Michael S Rutenberg, Christopher G Morris, et al.
Head & Neck|December 12, 2018
Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomasCatherine E Mercado, Adam L Holtzman, Ronny Rotondo, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Oral and Maxillofacial Surgery Clinics of North America|April 28, 2023
Future Perspective: Carbon Ion Radiotherapy for Head and Neck and Skull Base MalignanciesMichael S Rutenberg, Chris Beltran
Journal of Gastrointestinal Oncology|March 17, 2020
Proton beam radiotherapy for pancreas cancerMichael S Rutenberg, Romaine C Nichols
Trends in Molecular Medicine|April 27, 2004
Cell fusion and reprogramming: resolving our transdifferencesNemanja Rodić, Michael S Rutenberg, Naohiro Terada
Current Hematologic Malignancy Reports|May 21, 2014
Proton therapy for Hodgkin lymphomaMichael S Rutenberg, Stella Flampouri, Bradford S Hoppe
Practical Radiation Oncology|December 13, 2024
Reirradiation in the Management of Locally Recurrent Rectal AdenocarcinomaMichael S Rutenberg, Michael D Chuong, Jessica M Frakes
Current Treatment Options in Oncology|March 2, 2021
The Role of Radiation Therapy for Symptomatic Desmoid TumorsWen Shen Looi, Daniel J Indelicato, Michael S Rutenberg
International Journal of Hematology|February 26, 2004
Stem cell plasticity, beyond alchemyMichael S Rutenberg, Takashi Hamazaki, Amar M Singh, et al.
Journal of Applied Clinical Medical Physics|April 26, 2024
Technical note: A comparison of in-house 3D-printed and commercially available patient-specific skin collimators for use with electron beam therapySteven M Herchko, Michael S Rutenberg, Chris J Beltran, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer: a phase II trialCooper T Rapp, Michael S Rutenberg, Christopher G Morris, et al.
Head & Neck|December 12, 2018
Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomasCatherine E Mercado, Adam L Holtzman, Ronny Rotondo, et al.
Pageof 4